The present invention is directed to methods and compositions for improving pulmonary surfactant catabolism. More specifically, the specification describes methods and compositions for making and using a lysosomal phospholipase A2 in methods for the diagnosis, and treatment of disorders of phospholipid catabolism such as pulmonary alveolar proteinosis.

 
Web www.patentalert.com

< Antimicrobial chelates

> Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics

> Bacillus subtilis var. chungkookjang producing high molecular weight poly-gamma-glutamic acid

~ 00539